V

Viol Co Ltd
KOSDAQ:335890

Watchlist Manager
Viol Co Ltd
KOSDAQ:335890
Watchlist
Price: 12 500 KRW Market Closed
Market Cap: 730.3B KRW
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Viol Co Ltd stock under the Base Case scenario is 10 909.69 KRW. Compared to the current market price of 12 500 KRW, Viol Co Ltd is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
10 909.69 KRW
Overvaluation 13%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

9.6
P/S
P/S
Price to Sales
9.6
vs History
27
vs Industry
20
Median 3Y
8.3
Median 5Y
7.9
Industry
2.3
Forward
10.5
More Details
17.3
P/E
P/E
Price to Earnings
17.3
vs History
45
vs Industry
36
Median 3Y
18.5
Median 5Y
15.8
Industry
22
Forward
20.8
More Details
23.3
P/OCF
P/OCF
Price to OCF
23.3
vs History
37
vs Industry
23
Median 3Y
21.5
Median 5Y
20.1
Industry
14.3
More Details
24.9
P/FCFE
P/FCFE
Price to FCFE
24.9
vs History
30
vs Industry
24
Median 3Y
22.9
Median 5Y
21.3
Industry
20
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
24
vs Industry
14
Median 3Y
6.7
Median 5Y
6.1
Industry
2.2
More Details
8.6
EV/S
EV/S
Enterprise Value to Sales
8.6
vs History
30
vs Industry
22
Median 3Y
7.1
Median 5Y
6.8
Industry
2.4
Forward
9.3
More Details
10.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.4
vs History
45
vs Industry
31
Median 3Y
9.4
Median 5Y
9.8
Industry
5
More Details
13.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.8
vs History
59
vs Industry
32
Median 3Y
15.1
Median 5Y
15.9
Industry
11.6
Forward
15.8
More Details
13.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.8
vs History
59
vs Industry
37
Median 3Y
15.1
Median 5Y
16.7
Industry
15.9
Forward
16.1
More Details
20.7
EV/OCF
EV/OCF
Enterprise Value to OCF
20.7
vs History
37
vs Industry
28
Median 3Y
18.9
Median 5Y
17.6
Industry
14.3
More Details
21.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.7
vs History
32
vs Industry
27
Median 3Y
20.1
Median 5Y
17.9
Industry
18
More Details
26.6
EV/IC
EV/IC
Enterprise Value to IC
26.6
vs History
29
vs Industry
4
Median 3Y
22.8
Median 5Y
19.3
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Viol Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Viol Co Ltd
KOSDAQ:335890
721.8B KRW 9.6 17.3 13.8 13.8
US
Abbott Laboratories
NYSE:ABT
228.6B USD 5.4 16.9 22 31.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.5B USD 21.1 74.1 59.7 72.6
US
Boston Scientific Corp
NYSE:BSX
152.7B USD 8.7 75.1 35.4 49.3
US
Stryker Corp
NYSE:SYK
148.8B USD 6.4 52.1 25.7 31
IE
Medtronic PLC
NYSE:MDT
115.3B USD 3.4 24.7 13.8 19.6
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR 2.2 24.7 13.9 19.3
US
Becton Dickinson and Co
NYSE:BDX
50.4B USD 2.4 33.2 13.2 24.7
US
Edwards Lifesciences Corp
NYSE:EW
45.9B USD 8.3 11 25.2 27.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.1B USD 11 48.1 34.1 38.1
US
Resmed Inc
NYSE:RMD
37.4B USD 7.4 28.5 20.3 23

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 267,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.